.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
Deloitte
Argus Health
Colorcon
Mallinckrodt
Express Scripts
Federal Trade Commission
Cerilliant
Healthtrust
Boehringer Ingelheim

Generated: December 16, 2017

DrugPatentWatch Database Preview

Suppliers and packages for NDA: 020786

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAsanofi-aventis U.S. LLC0088-1090-47100 TABLET, EXTENDED RELEASE in 1 BOTTLE (0088-1090-47)
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAsanofi-aventis U.S. LLC0088-1090-49100 TABLET, EXTENDED RELEASE in 1 BLISTER PACK (0088-1090-49)
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAsanofi-aventis U.S. LLC0088-1090-55500 TABLET, EXTENDED RELEASE in 1 BOTTLE (0088-1090-55)
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDARebel Distributors Corp21695-820-1414 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (21695-820-14)
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDARebel Distributors Corp21695-931-204 BLISTER PACK in 1 CARTON (21695-931-20) > 5 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAChattem, Inc.41167-4310-42 BLISTER PACK in 1 CARTON (41167-4310-4) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAChattem, Inc.41167-4310-63 BLISTER PACK in 1 CARTON (41167-4310-6) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAChattem, Inc.41167-4310-21 BLISTER PACK in 1 CARTON (41167-4310-2) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAA-S Medication Solutions50090-1203-01 BLISTER PACK in 1 CARTON (50090-1203-0) > 10 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK
Sanofi Aventis UsALLEGRA-D 12 HOUR ALLERGY AND CONGESTIONfexofenadine hydrochloride; pseudoephedrine hydrochlorideTABLET, EXTENDED RELEASE;ORAL020786NDAPhysicians Total Care, Inc.54868-4258-310 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (54868-4258-3)
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Federal Trade Commission
Baxter
Merck
Cantor Fitzgerald
McKesson
Boehringer Ingelheim
Cipla
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot